E-LIB Suche - Ergebnisse für: Havrdova, E.

1

PND18 - PROGRESSION OF DISABILITY IN PRIMARY PROGRESSIVE MU..:

Jhuti, GS ; Freitas, R ; Bennett, I...
Value in Health. 21 (2018) - p. S332 , 2018

Link: https://doi.org/10.1016/..

2

Survey of diagnostic and treatment practices for multiple s..:

Fernández, O. ; Delvecchio, M. ; Edan, G....
European Journal of Neurology. 25 (2018) 5 - p. 739-746 , 2018

Link: https://doi.org/10.1111/..

3

Anti‐inflammatory disease‐modifying treatment and disabilit..:

Lorscheider, J. ; Kuhle, J. ; Izquierdo, G....
European Journal of Neurology. 26 (2018) 2 - p. 363-370 , 2018

Link: https://doi.org/10.1111/..

4

ECTRIMS/EAN guideline on the pharmacological treatment of p..:

Montalban, X. ; Gold, R. ; Thompson, A. J....
European Journal of Neurology. 25 (2018) 2 - p. 215-237 , 2018

Link: https://doi.org/10.1111/..

5

Effect of delayed‐release dimethyl fumarate on no evidence ..:

Havrdova, E. ; Giovannoni, G. ; Gold, R....
European Journal of Neurology. 24 (2017) 5 - p. 726-733 , 2017

Link: https://doi.org/10.1111/..

6

Survey of diagnostic and treatment practices for multiple s..:

Fernández, O. ; Delvecchio, M. ; Edan, G....
European Journal of Neurology. 24 (2017) 3 - p. 516-522 , 2017

Link: https://doi.org/10.1111/..

7

Daclizumab high‐yield process reduced the evolution of new ..:

Radue, E.‐W. ; Sprenger, T. ; Vollmer, T....
European Journal of Neurology. 23 (2016) 2 - p. 412-415 , 2016

Link: https://doi.org/10.1111/..

8

Risk of early relapse following the switch from injectables..:

Spelman, T. ; Mekhael, L. ; Burke, T....
European Journal of Neurology. 23 (2016) 4 - p. 729-736 , 2016

Link: https://doi.org/10.1111/..

9

Identification of multiple sclerosis patients at highest ri..:

Uher, T. ; Vaneckova, M. ; Sormani, M. P....
European Journal of Neurology. 24 (2016) 2 - p. 292-301 , 2016

Link: https://doi.org/10.1111/..

10

Standardizing terms, definitions and concepts for describin..:

ABIRISK Consortium ; Rup, B ; Pallardy, M...
Clinical and Experimental Immunology. 181 (2015) 3 - p. 385-400 , 2015

Link: https://doi.org/10.1111/..

11

BREMSO: a simple score to predict early the natural course ..:

Bergamaschi, R. ; Montomoli, C. ; Mallucci, G....
European Journal of Neurology. 22 (2015) 6 - p. 981-989 , 2015

Link: https://doi.org/10.1111/..

12

'Hidden' factors influencing quality of life in patients wi..:

Lysandropoulos, A. P. ; Havrdova, E.
European Journal of Neurology. 22 (2015) S2 - p. 28-33 , 2015

Link: https://doi.org/10.1111/..

13

Daclizumab HYP reduces total disability burden of patients ..:

Boyko, A. ; Kappos, L. ; Rose, J....
Journal of the Neurological Sciences. 357 (2015) - p. e300-e301 , 2015

Link: https://doi.org/10.1016/..

14

Early magnetic resonance imaging predictors of clinical pro..:

Uher, T. ; Horakova, D. ; Kalincik, T....
European Journal of Neurology. 22 (2015) 7 - p. 1113-1123 , 2015

Link: https://doi.org/10.1111/..

15

Efficacy and safety of alemtuzumab in patients with relapsi..:

Kieseier, B.C. ; Sahraian, M.A. ; Coles, A.J....
Multiple Sclerosis and Related Disorders. 3 (2014) 6 - p. 756 , 2014

Link: https://doi.org/10.1016/..